Listed

IDEAYA Biosciences, Inc.

IDYANasdaqCIK 1676725HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$8.9m, Q2 FY2026
Operating income−$122.3m, Q2 FY2026
Net income−$112.5m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m8.0Revenue, Q3 FY2023, three months to 2023-09-30$8.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-04, accession 0000950170-24-120675.Report this figure3.9Revenue, Q4 FY2023, three months to 2023-12-31$3.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001193125-26-054533. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-05-07, accession 0000950170-24-054466.Report this figure0.0Revenue, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-08-06, accession 0000950170-24-091823.Report this figure0.0Revenue, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-04, accession 0000950170-24-120675.Report this figure7.0Revenue, Q4 FY2024, three months to 2024-12-31$7.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001193125-26-054533. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported208Revenue, Q3 FY2025, three months to 2025-09-30$207.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figure10.9Revenue, Q4 FY2025, three months to 2025-12-31$10.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0001193125-26-054533. Derived: 12-month figure less the 9-month figure.Report this figure6.6Revenue, Q1 FY2026, three months to 2026-03-31$6.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure8.9Revenue, Q2 FY2026, three months to 2026-06-30$8.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure
Research and development$m33.7Research and development, Q3 FY2023, three months to 2023-09-30$33.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-04, accession 0000950170-24-120675.Report this figure38.8Research and development, Q4 FY2023, three months to 2023-12-31$38.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-17, accession 0001193125-26-054533. Derived: 12-month figure less the 9-month figure.Report this figure42.8Research and development, Q1 FY2024, three months to 2024-03-31$42.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-06, accession 0000950170-25-064438.Report this figure54.5Research and development, Q2 FY2024, three months to 2024-06-30$54.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-05, accession 0000950170-25-102967.Report this figure57.2Research and development, Q3 FY2024, three months to 2024-09-30$57.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figure140Research and development, Q4 FY2024, three months to 2024-12-31$140.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-17, accession 0001193125-26-054533. Derived: 12-month figure less the 9-month figure.Report this figure70.9Research and development, Q1 FY2025, three months to 2025-03-31$70.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure74.2Research and development, Q2 FY2025, three months to 2025-06-30$74.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure83.0Research and development, Q3 FY2025, three months to 2025-09-30$83.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figure86.6Research and development, Q4 FY2025, three months to 2025-12-31$86.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure95.7Research and development, Q1 FY2026, three months to 2026-03-31$95.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure109Research and development, Q2 FY2026, three months to 2026-06-30$108.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure
Operating income$m(33.5)Operating income, Q3 FY2023, three months to 2023-09-30−$33.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-04, accession 0000950170-24-120675.Report this figure(41.9)Operating income, Q4 FY2023, three months to 2023-12-31−$41.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0001193125-26-054533. Derived: 12-month figure less the 9-month figure.Report this figure(51.0)Operating income, Q1 FY2024, three months to 2024-03-31−$51.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0000950170-25-064438.Report this figure(64.9)Operating income, Q2 FY2024, three months to 2024-06-30−$64.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-05, accession 0000950170-25-102967.Report this figure(66.9)Operating income, Q3 FY2024, three months to 2024-09-30−$66.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figure(144)Operating income, Q4 FY2024, three months to 2024-12-31−$144.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0001193125-26-054533. Derived: 12-month figure less the 9-month figure.Report this figure(84.4)Operating income, Q1 FY2025, three months to 2025-03-31−$84.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure(88.8)Operating income, Q2 FY2025, three months to 2025-06-30−$88.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure108Operating income, Q3 FY2025, three months to 2025-09-30$108.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figure(94.6)Operating income, Q4 FY2025, three months to 2025-12-31−$94.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0001193125-26-054533. Derived: 12-month figure less the 9-month figure.Report this figure(109)Operating income, Q1 FY2026, three months to 2026-03-31−$108.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure(122)Operating income, Q2 FY2026, three months to 2026-06-30−$122.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-04, accession 0000950170-24-120675.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-17, accession 0001193125-26-054533. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-06, accession 0000950170-25-064438.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-05, accession 0000950170-25-102967.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-04, accession 0000950170-24-120675.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-17, accession 0001193125-26-054533. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-05, accession 0000950170-25-102967.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001193125-25-264632. Derived: 9-month figure less the 6-month figure.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-17, accession 0001193125-26-054533. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-04, accession 0001193125-26-332774. Derived: 6-month figure less the 3-month figure.Report this figure
Net income$m(27.4)Net income, Q3 FY2023, three months to 2023-09-30−$27.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-04, accession 0000950170-24-120675.Report this figure(34.0)Net income, Q4 FY2023, three months to 2023-12-31−$34.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0001193125-26-054533. Derived: 12-month figure less the 9-month figure.Report this figure(39.6)Net income, Q1 FY2024, three months to 2024-03-31−$39.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-06, accession 0000950170-25-064438.Report this figure(52.8)Net income, Q2 FY2024, three months to 2024-06-30−$52.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-05, accession 0000950170-25-102967.Report this figure(51.8)Net income, Q3 FY2024, three months to 2024-09-30−$51.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figure(130)Net income, Q4 FY2024, three months to 2024-12-31−$130.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0001193125-26-054533. Derived: 12-month figure less the 9-month figure.Report this figure(72.2)Net income, Q1 FY2025, three months to 2025-03-31−$72.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure(77.5)Net income, Q2 FY2025, three months to 2025-06-30−$77.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure119Net income, Q3 FY2025, three months to 2025-09-30$119.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figure(83.3)Net income, Q4 FY2025, three months to 2025-12-31−$83.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-17, accession 0001193125-26-054533. Derived: 12-month figure less the 9-month figure.Report this figure(98.5)Net income, Q1 FY2026, three months to 2026-03-31−$98.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure(112)Net income, Q2 FY2026, three months to 2026-06-30−$112.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure
Diluted EPS$ per share(0.46)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-04, accession 0000950170-24-120675.Report this figurenot reported(0.53)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0000950170-25-064438.Report this figure(0.68)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.68 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-05, accession 0000950170-25-102967.Report this figure(0.60)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.60 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figurenot reported(0.82)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.82 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure(0.88)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.88 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure1.33Diluted EPS, Q3 FY2025, three months to 2025-09-30$1.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figurenot reported(1.11)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure(1.22)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure
Basic EPS$ per share(0.46)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-04, accession 0000950170-24-120675.Report this figurenot reported(0.53)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.53 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0000950170-25-064438.Report this figure(0.68)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.68 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-05, accession 0000950170-25-102967.Report this figure(0.60)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.60 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figurenot reported(0.82)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.82 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure(0.88)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.88 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure1.35Basic EPS, Q3 FY2025, three months to 2025-09-30$1.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figurenot reported(1.11)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure(1.22)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure

Balance sheet

Cash and equivalents$272.6m, Q2 FY2026
Shareholders' equity$1.20bn, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m152Cash and equivalents, Q3 FY2023, at 2023-09-30$151.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-04, accession 0000950170-24-120675.Report this figure157Cash and equivalents, FY2023, at 2023-12-31$157.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-17, accession 0001193125-26-054533.Report this figure108Cash and equivalents, Q1 FY2024, at 2024-03-31$108.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0000950170-25-064438.Report this figure183Cash and equivalents, Q2 FY2024, at 2024-06-30$183.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-05, accession 0000950170-25-102967.Report this figure400Cash and equivalents, Q3 FY2024, at 2024-09-30$400.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figure84.4Cash and equivalents, FY2024, at 2024-12-31$84.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-17, accession 0001193125-26-054533.Report this figure130Cash and equivalents, Q1 FY2025, at 2025-03-31$130.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure115Cash and equivalents, Q2 FY2025, at 2025-06-30$114.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure299Cash and equivalents, Q3 FY2025, at 2025-09-30$298.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figure113Cash and equivalents, FY2025, at 2025-12-31$112.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure158Cash and equivalents, Q1 FY2026, at 2026-03-31$157.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure273Cash and equivalents, Q2 FY2026, at 2026-06-30$272.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure
Current assets$m482Current assets, Q3 FY2023, at 2023-09-30$482.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0000950170-23-060206.Report this figure533Current assets, FY2023, at 2023-12-31$532.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-18, accession 0000950170-25-022183.Report this figure709Current assets, Q1 FY2024, at 2024-03-31$709.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0000950170-24-054466.Report this figure713Current assets, Q2 FY2024, at 2024-06-30$713.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091823.Report this figure932Current assets, Q3 FY2024, at 2024-09-30$932.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-04, accession 0000950170-24-120675.Report this figure690Current assets, FY2024, at 2024-12-31$689.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-17, accession 0001193125-26-054533.Report this figure708Current assets, Q1 FY2025, at 2025-03-31$707.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064438.Report this figure686Current assets, Q2 FY2025, at 2025-06-30$685.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-05, accession 0000950170-25-102967.Report this figure803Current assets, Q3 FY2025, at 2025-09-30$802.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figure667Current assets, FY2025, at 2025-12-31$666.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure696Current assets, Q1 FY2026, at 2026-03-31$696.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure864Current assets, Q2 FY2026, at 2026-06-30$864.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure
Total assets$m533Total assets, Q3 FY2023, at 2023-09-30$532.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0000950170-23-060206.Report this figure649Total assets, FY2023, at 2023-12-31$649.3m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-18, accession 0000950170-25-022183.Report this figure962Total assets, Q1 FY2024, at 2024-03-31$961.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0000950170-24-054466.Report this figure974Total assets, Q2 FY2024, at 2024-06-30$973.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0000950170-24-091823.Report this figure1,240Total assets, Q3 FY2024, at 2024-09-30$1.24bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-04, accession 0000950170-24-120675.Report this figure1,124Total assets, FY2024, at 2024-12-31$1.12bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-17, accession 0001193125-26-054533.Report this figure1,101Total assets, Q1 FY2025, at 2025-03-31$1.10bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0000950170-25-064438.Report this figure1,041Total assets, Q2 FY2025, at 2025-06-30$1.04bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-05, accession 0000950170-25-102967.Report this figure1,185Total assets, Q3 FY2025, at 2025-09-30$1.19bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figure1,109Total assets, FY2025, at 2025-12-31$1.11bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure1,030Total assets, Q1 FY2026, at 2026-03-31$1.03bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure1,310Total assets, Q2 FY2026, at 2026-06-30$1.31bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure
Current liabilities$m24.9Current liabilities, Q3 FY2023, at 2023-09-30$24.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0000950170-23-060206.Report this figure27.1Current liabilities, FY2023, at 2023-12-31$27.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-18, accession 0000950170-25-022183.Report this figure25.0Current liabilities, Q1 FY2024, at 2024-03-31$25.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0000950170-24-054466.Report this figure40.7Current liabilities, Q2 FY2024, at 2024-06-30$40.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0000950170-24-091823.Report this figure40.7Current liabilities, Q3 FY2024, at 2024-09-30$40.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-04, accession 0000950170-24-120675.Report this figure46.1Current liabilities, FY2024, at 2024-12-31$46.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-17, accession 0001193125-26-054533.Report this figure50.8Current liabilities, Q1 FY2025, at 2025-03-31$50.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0000950170-25-064438.Report this figure55.3Current liabilities, Q2 FY2025, at 2025-06-30$55.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-05, accession 0000950170-25-102967.Report this figure64.5Current liabilities, Q3 FY2025, at 2025-09-30$64.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figure58.8Current liabilities, FY2025, at 2025-12-31$58.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure64.8Current liabilities, Q1 FY2026, at 2026-03-31$64.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure82.7Current liabilities, Q2 FY2026, at 2026-06-30$82.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure
Total liabilities$m24.9Total liabilities, Q3 FY2023, at 2023-09-30$24.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0000950170-23-060206.Report this figure28.2Total liabilities, FY2023, at 2023-12-31$28.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-18, accession 0000950170-25-022183.Report this figure26.2Total liabilities, Q1 FY2024, at 2024-03-31$26.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-07, accession 0000950170-24-054466.Report this figure42.0Total liabilities, Q2 FY2024, at 2024-06-30$42.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-06, accession 0000950170-24-091823.Report this figure59.5Total liabilities, Q3 FY2024, at 2024-09-30$59.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-04, accession 0000950170-24-120675.Report this figure64.9Total liabilities, FY2024, at 2024-12-31$64.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-17, accession 0001193125-26-054533.Report this figure76.5Total liabilities, Q1 FY2025, at 2025-03-31$76.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0000950170-25-064438.Report this figure81.6Total liabilities, Q2 FY2025, at 2025-06-30$81.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-05, accession 0000950170-25-102967.Report this figure93.1Total liabilities, Q3 FY2025, at 2025-09-30$93.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figure86.4Total liabilities, FY2025, at 2025-12-31$86.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure93.1Total liabilities, Q1 FY2026, at 2026-03-31$93.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure111Total liabilities, Q2 FY2026, at 2026-06-30$110.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure
Shareholders' equity$m508Shareholders' equity, Q3 FY2023, at 2023-09-30$508.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-04, accession 0000950170-24-120675.Report this figure621Shareholders' equity, FY2023, at 2023-12-31$621.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-17, accession 0001193125-26-054533.Report this figure935Shareholders' equity, Q1 FY2024, at 2024-03-31$935.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-05, accession 0000950170-25-102967.Report this figure932Shareholders' equity, Q2 FY2024, at 2024-06-30$931.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figure1,180Shareholders' equity, Q3 FY2024, at 2024-09-30$1.18bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figure1,059Shareholders' equity, FY2024, at 2024-12-31$1.06bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure1,024Shareholders' equity, Q1 FY2025, at 2025-03-31$1.02bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure960Shareholders' equity, Q2 FY2025, at 2025-06-30$959.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure1,092Shareholders' equity, Q3 FY2025, at 2025-09-30$1.09bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figure1,023Shareholders' equity, FY2025, at 2025-12-31$1.02bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure937Shareholders' equity, Q1 FY2026, at 2026-03-31$937.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure1,199Shareholders' equity, Q2 FY2026, at 2026-06-30$1.20bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure

Cash flow

Operating cash flow−$88.2m, Q2 FY2026
Capital expenditure$866.0k, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(30.2)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$30.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-04, accession 0000950170-24-120675. Derived: 9-month figure less the 6-month figure.Report this figure(23.7)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$23.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0001193125-26-054533. Derived: 12-month figure less the 9-month figure.Report this figure(43.8)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$43.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0000950170-25-064438.Report this figure(32.9)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$32.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-05, accession 0000950170-25-102967. Derived: 6-month figure less the 3-month figure.Report this figure(49.2)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$49.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001193125-25-264632. Derived: 9-month figure less the 6-month figure.Report this figure(122)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$121.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0001193125-26-054533. Derived: 12-month figure less the 9-month figure.Report this figure(60.3)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$60.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure(62.5)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$62.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001193125-26-332774. Derived: 6-month figure less the 3-month figure.Report this figure142Operating cash flow, Q3 FY2025, three months to 2025-09-30$142.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001193125-25-264632. Derived: 9-month figure less the 6-month figure.Report this figure(90.5)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$90.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0001193125-26-054533. Derived: 12-month figure less the 9-month figure.Report this figure(75.2)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$75.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure(88.2)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$88.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001193125-26-332774. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.6Capital expenditure, Q3 FY2023, three months to 2023-09-30$603.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-04, accession 0000950170-24-120675. Derived: 9-month figure less the 6-month figure.Report this figure0.8Capital expenditure, Q4 FY2023, three months to 2023-12-31$838.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0001193125-26-054533. Derived: 12-month figure less the 9-month figure.Report this figure1.3Capital expenditure, Q1 FY2024, three months to 2024-03-31$1.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-06, accession 0000950170-25-064438.Report this figure1.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$973.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-05, accession 0000950170-25-102967. Derived: 6-month figure less the 3-month figure.Report this figure0.5Capital expenditure, Q3 FY2024, three months to 2024-09-30$457.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001193125-25-264632. Derived: 9-month figure less the 6-month figure.Report this figure1.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0001193125-26-054533. Derived: 12-month figure less the 9-month figure.Report this figure1.3Capital expenditure, Q1 FY2025, three months to 2025-03-31$1.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure0.7Capital expenditure, Q2 FY2025, three months to 2025-06-30$663.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-04, accession 0001193125-26-332774. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$42.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001193125-25-264632. Derived: 9-month figure less the 6-month figure.Report this figure0.3Capital expenditure, Q4 FY2025, three months to 2025-12-31$333.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0001193125-26-054533. Derived: 12-month figure less the 9-month figure.Report this figure1.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$967.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure0.9Capital expenditure, Q2 FY2026, three months to 2026-06-30$866.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-04, accession 0001193125-26-332774. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)92.06m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares41.1Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3041,109,571 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0000950170-23-060206.Report this figure48.4Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3148,370,074 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0000950170-24-054466.Report this figure56.3Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3056,251,130 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0000950170-24-091823.Report this figure60.0Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3059,999,449 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-04, accession 0000950170-24-120675.Report this figure75.1Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3175,108,484 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0000950170-25-064438.Report this figure78.0Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3077,962,730 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-05, accession 0000950170-25-102967.Report this figure86.2Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3086,188,510 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figure88.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3188,356,335 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure88.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3088,472,197 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure89.7Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3089,690,878 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001193125-25-264632.Report this figure88.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3188,699,754 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-05, accession 0001193125-26-206357.Report this figure92.1Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3092,061,452 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure

Shares outstanding: 96.49mShares outstanding, period not labelled, at 2026-07-3196,489,484 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-04, accession 0001193125-26-332774.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 4, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.